Home
/
LifeMD, Inc.
/
Financials
/
Quarterly
LifeMD, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LifeMD, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$3.13M
Nov 14, 2019
Q2
2019
Jun 30, 2019
$2.70M
Aug 14, 2019
Q1
2019
Mar 31, 2019
$2.70M
May 15, 2019
Q3
2018
Sep 30, 2018
$2.50M
Dec 4, 2018
Q2
2019
Jun 30, 2018
$2.04M
Aug 14, 2019
Q3
2019
Jun 30, 2018
$2.04M
Nov 14, 2019
Q1
2019
Mar 31, 2018
$1.61M
May 15, 2019
Q3
2018
Sep 30, 2017
$2.05M
Dec 4, 2018
Q2
2018
Jun 30, 2017
$660.1K
Aug 17, 2018
Q1
2018
Mar 31, 2017
$167.9K
Jun 27, 2018
Q3
2017
Sep 30, 2016
$1.38M
Nov 14, 2017
Q2
2017
Jun 30, 2016
$1.23M
Aug 14, 2017
Q1
2017
Mar 31, 2016
$1.64M
Jul 7, 2017
Q3
2016
Sep 30, 2015
$279.9K
Nov 13, 2017
Q2
2016
Jun 30, 2015
$277.4K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$288.3K
May 16, 2016
Q3
2015
Sep 30, 2014
$165.5K
Nov 13, 2015
Q2
2015
Jun 30, 2014
$196.6K
Aug 13, 2015
Q1
2015
Mar 31, 2014
$192.4K
May 14, 2015
Q3
2014
Sep 30, 2013
$94.7K
Nov 14, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$60.17M
Nov 17, 2025
Q3
2025
Jun 30, 2025
$62.67M
Nov 17, 2025
Q2
2025
Jun 30, 2025
$62.22M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$65.70M
May 6, 2025
Q3
2025
Mar 31, 2025
$64.13M
Nov 17, 2025
Q3
2025
Dec 31, 2024
$208.84M
Nov 17, 2025
Q3
2025
Sep 30, 2024
$53.27M
Nov 17, 2025
Q2
2025
Jun 30, 2024
$50.66M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$44.14M
May 6, 2025
Q3
2024
Sep 30, 2023
$38.61M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$35.95M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$33.13M
May 8, 2024
Q3
2023
Sep 30, 2022
$31.41M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$30.46M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$29.04M
May 12, 2023
Q3
2022
Sep 30, 2021
$24.95M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$22.31M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$18.20M
May 13, 2022
Q3
2021
Sep 30, 2020
$11.01M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$9.09M
Aug 13, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$5.00M
Nov 14, 2017
Q2
2017
Jun 30, 2017
$5.00M
Aug 14, 2017
Q1
2017
Mar 31, 2017
$5.00M
Jul 7, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.81M)
Nov 17, 2025
Q3
2025
Jun 30, 2025
($1.62M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($2.07M)
Aug 5, 2025
Q3
2025
Mar 31, 2025
($183.8K)
Nov 17, 2025
Q1
2025
Mar 31, 2025
$1.38M
May 6, 2025
Q3
2025
Dec 31, 2024
($21.41M)
Nov 17, 2025
Q3
2025
Sep 30, 2024
($4.66M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($6.88M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($6.77M)
May 6, 2025
Q3
2024
Sep 30, 2023
($6.12M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($6.73M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($4.01M)
May 8, 2024
Q3
2023
Sep 30, 2022
($7.28M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($13.02M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($13.30M)
May 12, 2023
Q3
2022
Sep 30, 2021
($14.35M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($16.83M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($11.60M)
May 13, 2022
Q3
2021
Sep 30, 2020
($20.62M)
Nov 10, 2021
Q2
2020
Jun 30, 2020
($3.38M)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.97M)
Nov 17, 2025
Q3
2025
Jun 30, 2025
($451.6K)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($906.8K)
Aug 5, 2025
Q1
2025
Mar 31, 2025
$2.54M
May 6, 2025
Q3
2025
Mar 31, 2025
$974.3K
Nov 17, 2025
Q3
2025
Dec 31, 2024
($18.28M)
Nov 17, 2025
Q3
2025
Sep 30, 2024
($4.00M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($6.31M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($6.17M)
May 6, 2025
Q3
2024
Sep 30, 2023
($4.57M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($4.90M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($2.85M)
May 8, 2024
Q3
2023
Sep 30, 2022
($7.07M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($12.90M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($13.11M)
May 12, 2023
Q3
2022
Sep 30, 2021
($12.59M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($16.13M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($11.92M)
May 13, 2022
Q3
2021
Sep 30, 2020
($20.53M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.22M)
Aug 13, 2021